Bitcoin is crypto’s bedrock, but it too will evolve
Special report: Bitcoin is the cryptocurrency most emblematic of the universe it helped establish and the popular digital currency has been the gateway for many [more…]
Market Highlights: Nvidia down another 7pc, Bitcoin dips below US$60k, and 5 small caps to watch
ASX 200 poised for a +0.5pc gain despite Wall Street’s mixed performance Nvidia’s stock dropped nearly -7pc, prompting concerns about peak valuation And tips to [more…]
SS1 eyes US$60m credit for silver paste facility
Sun Silver applies for US$60m tax credit to establish silver paste production facility Facility to be located near the company’s Maverick Springs silver project Silver [more…]
FREE WHELAN: The ‘Long Magnificent 7’ trade is almost as universal as it is overcrowded
In this Stockhead series, investment manager James Whelan, managing director Barclay Pearce Capital Asset Management, offers his insights on the key investment themes and trends in [more…]
Dr Boreham’s Crucible: Can this paediatrics-focused biotech live up to its huge pot-ential?
Is Neurotech (ASX:NTI) the next Neuren Pharmaceuticals, or has the boat sailed in terms of treating children with a suite of rare neurological disorders? For [more…]
Morgans: Tech firms must be earners in high-rate times
Morgans says pressure mounting on tech companies to be cash earners rather than cash burners Higher interest rates means less access to and higher costs [more…]
MoneyTalks: Taylor Collison bullish on Reckon’s legal sector strategy, slaps Outperform rating
Taylor Collison rates Reckon Outperform Reckon’s tailwind will come from the legal sector, says the broker Taylor also reckons that Reckon has financial stability out [more…]
Meteoric’s Caldeira is a true rare earths unicorn
The Caldeira project is an ionic adsorption clay-hosted REE play known for its size and grade Current resource of 619Mt at 2538ppm TREO still has [more…]
Micros with Majors: Renegade Exploration’s partnership with one of the world’s leading miners
Micros with Majors is Stockhead’s column profiling, and examining the stories behind, micro-cap ASX companies in partnerships with some of Australia’s, and the world’s, leading [more…]
Rise and Shine: Everything you need to know before the ASX opens
Today on Stockhead, Tim “Not a Doctor” Boreham delves into the paediatric pot-stock Neurotech, the oh-so-clever but sadly Freo-supporting Jess Cummins looks at micro-caps with [more…]
